AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 191 min read$SHC

Petras Michael B. Jr. sold $5.4M of SHC

Petras Michael B. Jr. (Executive Chairman) sold 294,515 shares of Sotera Health Co (SHC) at $18.50 ($5.45M total) on 2026-08-17.

Original reporting
SEC EDGAR · Petras Michael B. Jr.
Published Aug 19, 2026, 8:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$SHC
Bearish
medium confidence
Mentioned
$SHC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SHCBearishLow
01

Why it matters

The insider sale reduces the insider's ownership, which may be interpreted by investors as a negative signal.

02

Market read

Primary insider sell news; modest impact on SHC stock.

03

What to watch

Potential upcoming corporate actions or personal tax planning not disclosed.

Relevance 6/10Novelty 5/10Timing: filing date 2026-08-19

Background

Form 4 filings disclose insider transactions; this is the first public report of this sale.

Company-level read

Ticker impact

$SHCBearishMedium confidence
Context

Executive Chairman Michael B. Petras Jr. sold 294,515 shares for $5.45 M, reducing his stake to 397,912 shares.

Expected impact

Short-term downward pressure; price may dip 1‑2% on news.

Evidence & confidence

Insider sales by a top officer are material, but the amount is modest relative to market cap; impact likely limited.

Market effects

Sector

Minimal; health‑care sector unlikely to be affected.

Regional

None

Global

Low

Counterpoint

What could challenge this read

The sale could be unrelated to confidence; could be a planned liquidity event.

Key entities

  • Company
    Sotera Health Co

    Public health‑care services provider (ticker SHC).

  • Executive
    Michael B. Petras Jr.

    Executive Chairman and director of Sotera Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SHC insider trading history →

Related articles

AUG 19
$AVTRMed

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

Avantor (AVTR) reported Q2 revenue of $1.69B, flat YoY, beating estimates by 4.9%, with stock up 8.2%. Bruker (BRKR) reported $838.5M revenue, up 5.2% YoY, missing estimates by 1.9%, with stock down 11.6%. Sotera Health (SHC) reported $321.4M revenue, up 9.2% YoY, beating estimates by 3.8%, with stock up 2.9%. Bio-Techne (TECH) reported $321.2M revenue, up 1.3% YoY, beating estimates by 2%, with stock flat.

yahoo.com3 min
AUG 6
$SHCHighAI 9/10

Sotera Health Company: Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Sotera Health (Nasdaq: SHC) reported Q2 2026 net revenues up 9.2% (8.0% constant currency) to $?, with net income $54 million ($0.19/share) versus $8 million ($0.03) a year earlier. Adjusted EPS was $0.26, and Adjusted EBITDA margin rose to 51.6%. The company raised FY 2026 outlook for net revenues to $1.236-$1.254B and Adjusted EBITDA to $634-$643M.

finanznachrichten.de6 min
AUG 6
$SHCHigh

Sotera Health Co (SHC): Results of Operations and Financial Condition

Sotera Health Co (SHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook • Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 • Q2 2026 net income of $54 million or $0.19 per diluted share, comp

SEC EDGAR 8-K4 min